By API User
ALCOHOLICS ANONYMOUS’ 2025 MEMBER SURVEY ALCOHOLICS ANONYMOUS MEMBERS AND THEIR RECOVERY JOURNEYS Sydney. A recent survey of over 1,000 current AA participants across Australia has explored in detail how AA supports its members in their recovery from addiction. The results also emphasise … Continued
By API User
BEIJING–BUSINESS WIRE– Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Mr. Andrew Y. Yan and … Continued
By API User
Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis and prurigo nodularis1 Significant improvements in itch were observed as early as … Continued
By API User
Australians for Mental Health welcomes mental health spend in mid-year budget update Australians for Mental Health has welcomed the federal government’s decision to fund its election commitment of more than $1 billion for mental health care. The Mid-Year Economic and Fiscal Outlook released today confirms the mental health funding boosts, which will expand … Continued
By API User
300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases. Collaboration supports Indonesian Government’s agenda to enhance diagnostic access and build national healthcare resilience. Multi-year agreement builds on GE HealthCare’s continued investment in local manufacturing, capability building and knowledge transfer to … Continued
By API User
Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission. The first-in-class clinical candidate, MK-7602, has been developed through a longstanding collaboration between WEHI and global biopharmaceutical company MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA). Pre-clinical research now published in eBiomedicine, a … Continued
By API User
Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more … Continued
By API User
A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The Mending Broken Hearts (MBH) team won the 2025 International Heart Hackathon Finals earlier this month, beating 13 teams from more than 10 countries. The competition is the world’s first and only … Continued
By API User
17 December 2025 – Australians are being urged to prevent mosquito bites this summer, after research mapping studies from across the country found that warmer temperatures heighten the risk of Ross River Virus outbreaks, especially in riverland and coastal regions. The scoping review, led by the University of Adelaide, and published today in the … Continued
By API User
The Leukaemia Foundation has welcomed the announcement by the Malinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly … Continued
